Introduction


Difficult times ahead…? Andy Myall – Editor, Pathology in Practice


Welcome to the 2023 edition of The Biomedical Science Industry Handbook, providing comprehensive information on the full range of products and services available from the in vitro diagnostics (IVD) industry. Fully revised for 2023, this publication


PPi


features up-to-date listings across the IVD industry, ranging from point-of-care testing to the latest breakthroughs in molecular biology and genomics. As I write it seems that the UK is finally headed for a period of relative stability, following political and economic turmoil throughout the autumn which will reverberate for some time to come. Whatever your political persuasion, the


more pragmatic and measured approach of the new Prime Minister is to be welcomed; but his stacked ‘In’ tray, recent economic readjustments, the continued war in Ukraine and the warning of difficult decisions to come mean that even the most optimistic among us will be slightly apprehensive of what 2023 could bring us. Disquiet in the NHS remains and it is sadly highly likely that those who served the country so well during the pandemic across the health service will not be receiving the pay awards and investment they have been asking for. Exactly where the NHS and its needs rank within Rishi Sunak’s priorities is as yet unclear, but somehow I doubt many are holding their breath. Which points to further likely requests for our NHS to do more, with less. While COVID-19 remains a threat,


certainly to workplaces in the healthcare industry affected by staff


THE BIOMEDICAL SCIENCE INDUSTRY HANDBOOK 2023 l 5


absence, it as least seems that we are entering what may be the final phase of the pandemic. Worries remain though of the impact a resurgent flu virus could have – an issue expanded upon by Mark Reed of Pro-Lab


Diagnostics in his Foreword over the page. Within the IVD area, new regulation


continues to be a hot topic, with a recent extension of the standstill period delaying the full introduction of the updated Medical Device Regulations 2002 for a further year, until July 2024. This will see CE-marked devices able to be placed in the UK market up until that date, with transitional arrangements – due to be published in spring 2023 – to come into force at that point. Through recent years it is true to say that


the profile of diagnostics has never been higher, and further developments to take testing closer to patients and having them even more involved in their medical journey will only increase that awareness. Here’s to a successful 2023 to you all.


PATHOLOGY IN PRACTICE


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80